ArticleBlood cancer journal2026

Glucagon-like peptide-1 receptor agonists and risk for hematologic malignancies: a multicenter propensity score-matched analysis.

Pratik Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.